Trivitron Healthcare today announced the completion of a strategic investment in Kiran Medical Systems making Trivitron the most comprehensive product and solution provider in the country for medical imaging space.

The investment combines a cash component and a stock swap ensuring wealth maximisation for the shareholders of both companies. The agreement between the two companies also provides for Trivitron to increase its shareholding over the next few years. This investment further strengthens Trivitron’s presence in South/ South East Asia, Middle East and Africa, which are its key export markets and make an entry in to US, Europe, Japan and Latin America where Kiran has a strong presence.

As a result of this strategic investment, the board of directors for Kiran Medical will now have two members, Dr G S K Velu and Ramesh Verkot for Trivitron Healthcare. Ramesh Modi, CEO, Kiran Medical will continue to operate the business of Kiran as an independent entity, with complete operational freedom. A core cross functional group with representation from Kiran Medical and Trivitron Healthcare will evaluate synergies and implement strategies that benefit both the entities.

This investment enables Trivitron to extend its imaging product portfolio and now cater to the complete needs of radiologists and cardiologists across the globe and to increase its global foot print with a complete range of equipment, consumables, accessories and apparels in global imaging diagnostics market.

Kiran Medical global leader in image enhancement and radiation protection, manufactures products such as cassettes, screens, grids, shields and computer radiography systems, with a leadership position in US, Europe, Japan and Latin America.

Kiran exports its products to over 160 countries across the world; USA, Europe, Japan and Latin America being the primary markets. Both companies will benefit from cross contributions coming from each product portfolio, sharing of network in export markets and gaining from each other's innovation and manufacturing base and knowledge.

Kiran Medical, primarily a manufacturing company has world-class engineering capabilities and a state-of-the-art manufacturing facility measuring 70,000 sq ft in Mumbai. This strategic investment provides an opportunity for Trivitron to augment its offering by adding manufacturing of imaging accessories and radiation protection products from Kiran's portfolio.

Trivitron is currently present in imaging market in India through a joint venture between Trivitron Healthcare and Hitachi Aloka Medical Ltd (ATMT) which offers ultrasound ad color doppler. Through its association with Hologic Inc, USA, Trivitron offers digital mammography and bone densitometer. Trivitron has also acquired Pune based Vision Engineering to manufacture x-ray systems. Trivitron’s aim is to offer cost effective medical technology products in India and emerging markets of the world for better healthcare access.